We aim to systematically summarize current evidence on how ALKBH5-mediated demethylation of transcripts affects immune-related pathways, to distinguish its tumor-intrinsic versus immune-intrinsic modes of action, to evaluate its potential impact on immunotherapy responsiveness, and to highlight key challenges for future research and clinical translation. Here, ALKBH5 is linked to neoplasm.